Recent trends in sales of electronic nicotine devices and oral nicotine pouches by flavour
Tobacco Control · 30.12.2025 · tc-2025-059478
DOI: 10.1136/tc-2025-059478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tobacco Control, online erschienen am 30.12.2025. Verfasst von Clinton H Durney und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health Sciences, British Columbia Cancer Research Institute, Vancouver, British Columbia, Canada cdurney@bccrc.ca. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Center for Tobacco Products.
Abstract (Originalsprache)
Background
The landscape of tobacco and nicotine delivery products has rapidly evolved with the introduction of electronic nicotine delivery systems (ENDSs) and oral nicotine pouches (ONPs). Understanding sales trends and flavour preferences is critical for assessing these products’ public health impact and informing regulatory strategies.
Objective
To characterise recent trends in US sales of ENDS and ONPs from 2018 to 2023, overall and by flavour.
Methods
Information Resources retail sales data covering 40 states from 7 January 2018 to 16 July 2023, were used to document trends in ENDS and ONP sales from brick-and-mortar retailers, by product flavour (non-menthol, mint/menthol and tobacco/unflavoured) in 4 week periods.
Results
ENDS and ONP sales have shown significant growth, with notable fluctuations coinciding with public health concerns and regulatory announcements. Specifically, non-menthol flavoured ENDS initially experienced a decline in sales following regulatory actions in early 2020 but strongly rebounded thereafter. Meanwhile, ONP sales have increased steadily, dominated by mint/menthol flavours. These trends may reflect consumer flavour preferences as well as manufacturers’ strategic responses to policy changes. Sensitivity analyses using more recent sales data from 24 states confirm that these patterns persist.
Conclusions
Differences in ENDS and ONP sales trends by flavour type underscore the importance of ongoing, detailed monitoring of nicotine product sales and use, to clarify public health implications and guide regulation. Given the growing variety of nicotine and tobacco products available today, tobacco regulatory frameworks must consider trends across this rapidly evolving market to understand and mitigate associated public health risks.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Population Health Sciences, British Columbia Cancer Research Institute, Vancouver, British Columbia, Canada cdurney@bccrc.ca.
- Department of Population Health Sciences, British Columbia Cancer Research Institute, Vancouver, British Columbia, Canada.
- School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.
- Rutgers Cancer Institute, Rutgers University, New Brunswick, New Jersey, USA.
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA.
- Lombardi Comprehensive Cancer Centre, Georgetown University, Washinton, District of Columbia, USA.
Förderung
- NCI NIH HHS
- Center for Tobacco Products
Zitieren
APA
Durney, C. H., Meza, R., Jimenez-Mendoza, E., Xu, K., Levy, D. T., & Friedman, A. S. (2025). Recent trends in sales of electronic nicotine devices and oral nicotine pouches by flavour. Tobacco Control, tc-2025-059478. https://doi.org/10.1136/tc-2025-059478
Vancouver
Durney CH, Meza R, Jimenez-Mendoza E, Xu K, Levy DT, Friedman AS. Recent trends in sales of electronic nicotine devices and oral nicotine pouches by flavour. Tobacco Control. 2025:tc-2025-059478. doi:10.1136/tc-2025-059478
BibTeX
@article{Durney2025,
author = {Durney, Clinton H and Meza, Rafael and Jimenez-Mendoza, Evelyn and Xu, Ke and Levy, David T and Friedman, Abigail S},
title = {Recent trends in sales of electronic nicotine devices and oral nicotine pouches by flavour},
journal = {Tobacco Control},
year = {2025},
pages = {tc--2025--059478},
doi = {10.1136/tc-2025-059478}
}
EUVIMED